west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "SUN Feng" 12 results
  • STUDY OF BLOOD LIPID AND PROTEIN IN GALLSTONE PATIENT

    Objective To study the relation between the pathogenesis of gallstone and blood lipid and protein.Methods Then indexes of blood lipid and protein in 204 cases of gallstone patients were measured and analysed by statistical software SPSS. Results There was a significant difference between the gallstone group and control in the value of proalbumin, total cholesterol, high density lipoprotein and carrier protein B (P<0.01), the value of total protein, triglyceride, low density lipoprotein cholesterol, very low density lipoprotein cholesterol and carrier protein A1 were higher than those in the control (P<0.05). Conclusion The indexes mentioned above may play an important role in the gallstone formation.

    Release date:2016-09-08 02:00 Export PDF Favorites Scan
  • Development, elaboration and application of grade summary of finding table for network meta-analysis

    The summary of finding (SoF) table for network meta-analysis (NMA) was developed by the GRADE working group to facilitate and consolidate understanding NMA findings and GRADE certainty of evidence. This paper introduces the development process, the structure of NMA-SoF and limitations. A NMA publication was presented as an example to comprehensively illustrate the application of the NMA-SoF table.

    Release date:2021-01-26 04:48 Export PDF Favorites Scan
  • Experimental Study on Changes of Expression of AFP mRNA in Human Hepatocellular Carcinoma Tissues after Oral Xeloda Therapy

    【Abstract】Objective To explore the changes of expression of AFP mRNA in human hepatocellular carcinoma (HCC) tissues after oral Xeloda therapy.Methods Total RNA was extracted from HCC tissue samples collect after operation and nested reverse transcription polymerase chain reaction (RT-nested PCR) assay was performed to determine the expression of AFP mRNA in this study.Results The final product of AFP mRNA amplified by RT-PCR was 174 bp and by RT-nested PCR was 101 bp. The AFP mRNA is positive in 12 of 21 patients (positive rate 57.14%) amplified by RT-nested PCR assay in Xeloda treatment group which is much lower than control group: 18 of 20 patients (positive rate 90.00%),P<0.05.The serum AFP value of Xeloda treatment group 〔(23.2±12.8) μg/L〕 is much lower than that of control group 〔(39.6±24.3) μg/L〕 four weeks after operation (P<0.05). However, There was no difference between two groups in serum AFP value before operation.Conclusion Xeloda can effectively suppress the expression of AFP mRNA in human HCC tissues and lower it’s product serum AFP value.The clinical application of Xeloda in HCC patients deserve further study.

    Release date:2016-08-28 04:44 Export PDF Favorites Scan
  • The GRoLTS-checklist: guidelines for reporting on latent trajectory studies

    混合模型框架下的模型,如潜变量增长混合模型(latent growth mixture modeling,LGMM)或潜类别增长分析(latent class growth analysis,LCGA),因估算过程中涉及多个决策过程,导致潜变量轨迹分析结果的报告呈现多样性。为解决这一问题,指南制订小组按照系统化的制订流程,通过 4 轮德尔菲法调查,遵循专家小组意见,提出了各领域报告潜变量轨迹分析结果时需采用统一的标准,最终确定了报告轨迹研究结果必要的关键条目,发布了潜变量轨迹研究报告规范(guidelines for reporting on latent trajectory studies,GRoLTS),并利用 GRoLTS 评价了 38 篇使用 LGMM 或 LCGA 研究创伤后应激轨迹的论文的报告情况。

    Release date: Export PDF Favorites Scan
  • Methods for safety signal detection in healthcare databases: a literature review

    近十年,在药品不良反应监测领域,基于医疗保健数据库的安全信号检测方法受到越来越多的关注,已成为弥补自发报告固有局限性的重要手段。目前数据挖掘方法主要基于比值失衡分析法(disproportionality analysis)、传统药物流行病学设计(如自身对照设计)、序列对称分析(sequence symmetry analysis,SSA)、序贯统计检验(sequential statistical testing)、时序关联规则(temporal association rules)、监督机器学习(supervised machine learning,SML)、树状扫描统计量方法(tree-based scan statistic)等。本文从应用场景和实用性角度对医疗保健数据库中安全信号检测方法及其性能进行介绍。

    Release date:2021-05-25 02:52 Export PDF Favorites Scan
  • Risk factors for postoperative persistence of obstructive sleep apnea in children: a systematic review and meta-analysis

    ObjectiveTo systematically review the risk factors leading to postoperative persistence of children diagnosed with obstructive sleep apnea (OSA) after adenoidectomy and tonsillectomy. MethodsPubMed, EMbase, The Cochrane Library, ClinicalTrials.gov, CNKI, VIP, WanFang Data and SinoMed databases were electronically searched to collect case-control studies and cohort studies related to risk factors for postoperative persistence of OSA in children from inception to July 2019. Two reviewers independently screened literature, extracted data, and evaluated the risk of bias of the included studies. Meta-analysis was then performed using RevMan 5.3 software. ResultsA total of 12 cohort studies involving 1 659 OSA patients were included. Meta-analysis results showed that the risk of postoperative persistence of OSA in children with preoperative obesity was 3.47 times higher than that in non-obese children (RR=3.47, 95%CI 2.04 to 5.92, P<0.000 01). Compared with normal-weight children, obese children had 4.11 times higher risk of postoperative residual OSA (RR=4.11, 95%CI 1.68 to 10.07, P<0.000 01).ConclusionsPreoperative obesity is a risk factor for postoperative persistence of OSA in children. Due to the limited quantity and quality of included studies, more high-quality studies are needed to verity the above conclusions.

    Release date: Export PDF Favorites Scan
  • Efficacy and safety of Orlistat for obese patients with cardiovascular risk: a meta-analysis

    ObjectivesTo systematically review the efficacy and safety of Orlistat for obese patients with cardiovascular risk including hyperlipidemia, hypertension, diabetes and prediabetes.MethodsSinomed, CNKI, WanFang Data, PubMed, EMbase, The Cochrane Library and ClinicalTrails.gov databases were electronically searched to collect randomized controlled trials (RCTs) of Orlistat for obese patients with cardiovascular risk such as hyperlipemia, diabetes, prediabetes and hypertension from inception to Jan 7th, 2017. Two reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies. Then, meta-analysis was performed using Stata 14.0 software.ResultsA total of 28 RCTs were included. The results of meta-analysis showed that, compared with placebo, Orlistat could significantly reduce the weight (MD=–2.85, 95%CI –3.47 to –2.24, P=0.000), waist (MD=–2.45, 95%CI –3.07 to –1.83, P=0.000) and BMI (MD=–1.29, 95%CI –2.08 to –0.49, P=0.002) of patients. Orlistat could also control the blood pressure, blood glucose and other cardiovascular risk factors well. Compared with the blank control, Orlistat could improve the waist and parts of cardiovascular risk factors (P<0.05). The incidence of adverse events of Orlistat was slightly higher than that of placebo, but most could be self-healing.ConclusionsCurrent evidence shows that compared with placebo and blank control, Orlistat is effective for improving both weight loss and some cardiovascular risk factors. Due to limited quality and quantity of the included studies, more high quality studies are needed to verify above conclusion.

    Release date:2018-06-04 08:52 Export PDF Favorites Scan
  • Interpretation of preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for abstracts)

    This paper introduced the preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for abstracts), which was published in BMJ in March 2021. This paper presented the 12 items of checklist, explanations, and examples of complete reporting, to help domestic researchers to report complete and informative abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies.

    Release date: Export PDF Favorites Scan
  • Reporting guideline for systematic review: comparative analysis of PRISMA 2020 and PRISMA 2009

    The PRISMA aims to enhance the transparency and reporting quality of systematic reviews. PRISMA 2020 is an update version of PRISMA 2009, which was published in BMJ in March, 2021. This article compared the PRISMA 2020 and PRISMA 2009, interpreted PRISMA 2020 with representative examples, aiming to help Chinese scholars better understand and apply this reporting guideline, thus to improve the reporting quality of systematic reviews.

    Release date:2021-06-18 02:04 Export PDF Favorites Scan
  • Efficacy of treatments for β-coronaviruses associated respiratory diseases: a systematic review

    ObjectiveTo systematically review the efficacy of treatments for β-coronaviruses.MethodsPubMed, EMbase, Web of Science, The Cochrane Library, SinoMed, CNKI and WanFang Data databases were electronically searched to collect randomized controlled trials (RCTs) and non-randomized controlled trials (non-RCTs) of treatments for β-coronaviruses from inception to June 17th, 2020. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Meta-analysis was then performed using Stata 14.0 software.ResultsA total of 109 studies invoving 23 210 patients were included. The results of the systematic review showed that compared with standard of care, corticosteroids could reduce mortality and increase cure rate for COVID-19. However, chloroquine could decrease cure rate. In severe acute respiratory syndrome (SARS) patients, corticosteroids could decrease the cure rate. In Middle East respiratory syndrome (MERS) patients, ribavirin/interferon/both drugs showed higher mortality.ConclusionsThe currently limited evidence shows that corticosteroids may be effective to COVID-19 patients while having limited effects on SARS patients. Hydroxychloroquine or chloroquine may have negative effects on COVID-19 patients. Ribavirin/interferon may be harmful to MERS patients. Due to limited quality and quantity of the included studies, more high quality studies are needed to verify the above conclusions.

    Release date: Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content